Literature DB >> 9427315

Impairment of brain kynurenic acid production by glutamate metabotropic receptor agonists.

E M Urbanska1, T Kocki, T Saran, Z Kleinrok, W A Turski.   

Abstract

The role of glutamatergic mechanisms in kynurenic acid (KYNA) production was evaluated in vitro. The selective ionotropic agonists NMDA, kainate and AMPA did not affect KYNA synthesis. Agonists of metabotropic (mGLU) and ionotropic receptors: quisqualate, L-glutamate and L-aspartate as well as agonists of mGLU receptors: (+/-)-1-aminocyclopentane-trans-1,3-dicarboxylic acid (t-ACPD) and L-(+)-2-amino-4-phosphonobutyric acid (L-AP4) diminished KYNA production with different potency. None of the studied mGLU antagonists such as (S)-4-carboxyphenylglycine, alpha-ethylglutamic acid or (RS)-alpha-methylserine-O-phosphate affected the basic or L-glutamate-inhibited synthesis of KYNA. It might be hypothesized that the impairment of KYNA production following the application of mGLU receptor agonists is related to their effects exerted upon the novel subtype of mGLU receptor.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9427315     DOI: 10.1097/00001756-199711100-00017

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  12 in total

1.  Demonstration of kynurenine aminotransferases I and II and characterization of kynurenic acid synthesis in oligodendrocyte cell line (OLN-93).

Authors:  Katarzyna Wejksza; Wojciech Rzeski; Etsuo Okuno; Martyna Kandefer-Szerszen; Jan Albrecht; Waldemar A Turski
Journal:  Neurochem Res       Date:  2005-08       Impact factor: 3.996

2.  Correlations of Kynurenic Acid, 3-Hydroxykynurenine, sIL-2R, IFN-α, and IL-4 with Clinical Symptoms During Acute Relapse of Schizophrenia.

Authors:  Kinga Szymona; Barbara Zdzisińska; Hanna Karakuła-Juchnowicz; Tomasz Kocki; Martyna Kandefer-Szerszeń; Marta Flis; Wojciech Rosa; Ewa M Urbańska
Journal:  Neurotox Res       Date:  2017-03-08       Impact factor: 3.911

3.  New insight into the antidepressants action: modulation of kynurenine pathway by increasing the kynurenic acid/3-hydroxykynurenine ratio.

Authors:  Tomasz Kocki; Sebastian Wnuk; Renata Kloc; Janusz Kocki; Björn Owe-Larsson; Ewa M Urbanska
Journal:  J Neural Transm (Vienna)       Date:  2011-06-10       Impact factor: 3.575

4.  Novel aspect of ketone action: β-hydroxybutyrate increases brain synthesis of kynurenic acid in vitro.

Authors:  Iwona Chmiel-Perzyńska; Renata Kloc; Adam Perzyński; Sławomir Rudzki; Ewa M Urbańska
Journal:  Neurotox Res       Date:  2010-09-14       Impact factor: 3.911

5.  Kynurenic acid production in cultured bovine aortic endothelial cells. Homocysteine is a potent inhibitor.

Authors:  Katarzyna Wejksza; Wojciech Rzeski; Jolanta Parada-Turska; Barbara Zdzisinska; Robert Rejdak; Tomasz Kocki; Etsuo Okuno; Martyna Kandefer-Szerszen; Eberhart Zrenner; Waldemar A Turski
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-02-10       Impact factor: 3.000

6.  Kynurenic acid synthesis in bovine retinal slices--effect of glutamate agonists.

Authors:  T Zarnowski; M Bialek; R Rejdak; E Zrenner; A Junemann; Z Zagorski; T Kocki; W A Turski
Journal:  J Neural Transm (Vienna)       Date:  2006-02-09       Impact factor: 3.575

7.  Ammonia upregulates kynurenine aminotransferase II mRNA expression in rat brain: a role for astrocytic NMDA receptors?

Authors:  Marta Obara-Michlewska; Paulina Tuszyńska; Jan Albrecht
Journal:  Metab Brain Dis       Date:  2012-11-08       Impact factor: 3.584

8.  Alterations of amino acids and glutamate transport in the DBA/2J mouse retina; possible clues to degeneration.

Authors:  Frank Schuettauf; Sebastian Thaler; Sylvia Bolz; Julia Fries; Hubert Kalbacher; Anna Mankowska; David Zurakowski; Eberhart Zrenner; Robert Rejdak
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-08       Impact factor: 3.535

9.  Losartan Reverses Hippocampal Increase of Kynurenic Acid in Type 1 Diabetic Rats: A Novel Procognitive Aspect of Sartan Action.

Authors:  Iwona Chmiel-Perzyńska; Adam Perzyński; Bartosz Olajossy; Paulina Gil-Kulik; Janusz Kocki; Ewa M Urbańska
Journal:  J Diabetes Res       Date:  2019-10-13       Impact factor: 4.011

Review 10.  Kynurenine Aminotransferase Isozyme Inhibitors: A Review.

Authors:  Alireza Nematollahi; Guanchen Sun; Gayan S Jayawickrama; W Bret Church
Journal:  Int J Mol Sci       Date:  2016-06-15       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.